[go: up one dir, main page]

PL1711169T3 - Powlekane tabletki chlorowodorku wenlafaksyny o wydłużonym czasie uwalniania - Google Patents

Powlekane tabletki chlorowodorku wenlafaksyny o wydłużonym czasie uwalniania

Info

Publication number
PL1711169T3
PL1711169T3 PL04821278T PL04821278T PL1711169T3 PL 1711169 T3 PL1711169 T3 PL 1711169T3 PL 04821278 T PL04821278 T PL 04821278T PL 04821278 T PL04821278 T PL 04821278T PL 1711169 T3 PL1711169 T3 PL 1711169T3
Authority
PL
Poland
Prior art keywords
extended release
venlafaxine hydrochloride
release coated
coated minitablets
relates
Prior art date
Application number
PL04821278T
Other languages
English (en)
Inventor
Sampad Bhattacharya
Rajesh Kshirsagar
Mayank Joshi
Sandeep Pandita
Original Assignee
Alembic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd filed Critical Alembic Ltd
Publication of PL1711169T3 publication Critical patent/PL1711169T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL04821278T 2004-02-04 2004-10-27 Powlekane tabletki chlorowodorku wenlafaksyny o wydłużonym czasie uwalniania PL1711169T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN117MU2004 2004-02-04
IN980MU2004 2004-09-13
EP04821278A EP1711169B1 (en) 2004-02-04 2004-10-27 Extended release coated minitablets of venlafaxine hydrochloride
PCT/IN2004/000340 WO2005074895A1 (en) 2004-02-04 2004-10-27 Extended release coated microtablets of venlafaxine hydrochloride

Publications (1)

Publication Number Publication Date
PL1711169T3 true PL1711169T3 (pl) 2007-10-31

Family

ID=34809925

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04821278T PL1711169T3 (pl) 2004-02-04 2004-10-27 Powlekane tabletki chlorowodorku wenlafaksyny o wydłużonym czasie uwalniania

Country Status (22)

Country Link
US (1) US7807195B2 (pl)
EP (1) EP1711169B1 (pl)
JP (1) JP2007520547A (pl)
AT (1) ATE361743T1 (pl)
AU (1) AU2004315136B2 (pl)
BR (1) BRPI0418283A (pl)
CA (1) CA2555295C (pl)
CY (1) CY1106741T1 (pl)
DE (1) DE602004006443T2 (pl)
DK (1) DK1711169T3 (pl)
ES (1) ES2287813T3 (pl)
HR (1) HRP20070353T3 (pl)
IL (1) IL177243A0 (pl)
MX (1) MXPA06008854A (pl)
NO (1) NO20063809L (pl)
NZ (1) NZ548504A (pl)
PL (1) PL1711169T3 (pl)
PT (1) PT1711169E (pl)
RU (1) RU2340331C2 (pl)
SI (1) SI1711169T1 (pl)
UA (1) UA82597C2 (pl)
WO (1) WO2005074895A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
WO2004047718A2 (en) * 2002-11-28 2004-06-10 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci
WO2006136927A1 (en) * 2005-06-22 2006-12-28 Glenmark Pharmaceuticals Limited Extended release formulations comprising venlafaxine
US20080193524A1 (en) * 2005-07-28 2008-08-14 Dr. Reddy's Laboratories Ltd. Extended Release Venlafaxine Compositions
WO2007102169A1 (en) * 2006-03-08 2007-09-13 Jubilant Organosys Limited Extended release pharmaceutical formulation of venlafaxine and method of manufacturing the same
EP2010162A4 (en) * 2006-04-03 2013-01-09 Isa Odidi COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT
WO2007112574A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Extended release composition of venlafaxine
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
WO2008074145A1 (en) * 2006-12-20 2008-06-26 Genpharm Ulc Pharmaceutical composition comprising a hot-melt granulated lubricant
EP2124963A4 (en) * 2006-12-20 2010-03-17 Mylan Pharmaceuticals Ulc COMPOSITION WITH A BISPHOSPHONIC ACID IN COMBINATION WITH VITAMIN D
TWI391150B (zh) * 2008-01-22 2013-04-01 Taiwan Biotech Co Ltd 腸溶性長效塗覆芯與藥物劑型及其製造方法
CN101756934A (zh) * 2008-12-10 2010-06-30 上海复星普适医药科技有限公司 文拉法辛缓释制剂的制备方法
KR101787481B1 (ko) 2010-10-21 2017-10-18 롯데정밀화학 주식회사 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
WO2012104852A1 (en) 2011-01-31 2012-08-09 Serotech, Llc Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder
CN108366989B (zh) 2015-12-25 2020-11-03 富士胶片富山化学株式会社 含有1-(3-(2-(1-苯并噻吩-5-基-)乙氧基)丙基)氮杂环丁-3-醇或其盐的片剂

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
PE57198A1 (es) 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
DK1077692T3 (da) * 1998-05-15 2004-12-06 Warner Lambert Co Aminosyrestabiliserede gabapentin- og pregabalinpræparater og fremgangsmåder til fremstilling deraf
ATE357910T1 (de) 1999-11-22 2007-04-15 Alza Corp Osmotische darreichungsform mit zwei mantelschichten
US6346269B1 (en) * 2000-05-08 2002-02-12 Standard Chem. & Pharm. Co., Ltd. Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
US6350471B1 (en) * 2000-05-31 2002-02-26 Pharma Pass Llc Tablet comprising a delayed release coating
US6946146B2 (en) * 2001-04-18 2005-09-20 Nostrum Pharmaceuticals Inc. Coating for a sustained release pharmaceutical composition
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
JP2005516020A (ja) 2001-12-20 2005-06-02 ファルマシア・コーポレーション ゼロ次持続放出剤形およびその製造方法
EP1474123A1 (en) * 2002-01-03 2004-11-10 LEK Pharmaceuticals D.D. Controlled release pharmaceutical formulation containing venlafaxine
WO2003082805A1 (en) * 2002-03-28 2003-10-09 Synthon B.V. Low water-soluble venlafaxine salts
AU2003226752A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Venlafaxine base
IL149055A0 (en) * 2002-04-09 2002-11-10 Karma Pharm Ltd Extended release composition comprising as active compound venlafaxine hydrochloride
CN1674877A (zh) * 2002-06-07 2005-09-28 兰贝克赛实验室有限公司 控释的多单位药物释放系统
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US7058999B2 (en) * 2002-10-24 2006-06-13 Paramount Bed Co., Ltd. Electric bed and control apparatus and control method therefor
WO2004037226A2 (en) * 2002-10-25 2004-05-06 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions containing venlafaxine
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
WO2004069228A2 (en) * 2003-02-07 2004-08-19 Omega Farma Ehf. Sustained release formulations of venlafaxine
SI1502587T1 (sl) * 2003-07-30 2007-02-28 Pharmathen Sa Formulacija z zadrzevanim sproscanjem za Venlafaxin hidroklorid
US7016014B2 (en) * 2004-02-27 2006-03-21 Asml Netherlands B.V Lithographic apparatus and device manufacturing method

Also Published As

Publication number Publication date
SI1711169T1 (sl) 2007-10-31
CA2555295C (en) 2011-01-18
CA2555295A1 (en) 2005-08-18
KR20070000439A (ko) 2007-01-02
MXPA06008854A (es) 2007-01-23
PT1711169E (pt) 2007-07-23
AU2004315136B2 (en) 2010-06-17
UA82597C2 (uk) 2008-04-25
CY1106741T1 (el) 2012-05-23
NZ548504A (en) 2009-03-31
RU2340331C2 (ru) 2008-12-10
AU2004315136A1 (en) 2005-08-18
ATE361743T1 (de) 2007-06-15
DE602004006443D1 (de) 2007-06-21
RU2006129034A (ru) 2008-03-10
BRPI0418283A (pt) 2007-05-02
HRP20070353T3 (en) 2008-01-31
DE602004006443T2 (de) 2008-01-10
IL177243A0 (en) 2006-12-10
US20050169985A1 (en) 2005-08-04
JP2007520547A (ja) 2007-07-26
DK1711169T3 (da) 2007-09-17
EP1711169A1 (en) 2006-10-18
HK1091137A1 (en) 2007-01-12
EP1711169B1 (en) 2007-05-09
US7807195B2 (en) 2010-10-05
NO20063809L (no) 2006-08-25
WO2005074895A1 (en) 2005-08-18
ES2287813T3 (es) 2007-12-16

Similar Documents

Publication Publication Date Title
IL177243A0 (en) Extended release coated minitablets of venlafaxine hydrochloride
WO2008027557A3 (en) Topiramate compositions and methods of enhancing its bioavailability
AP2012006231A0 (en) Capsule formulation of pirfenidone and pharmaceutically acceptable excipients.
MX2009001711A (es) Formulaciones de liberacion sostenida de topiramato.
EA200900264A1 (ru) Композиции флибансерина и способ их приготовления
PT2328618T (pt) Composição farmacêutica de n-[2,4-bis(1,1-dimetiletil)-5-hidroxifenil]-1,4-di-hidro-4-oxoquinolino-3-carboxamida e sua administração
MY148844A (en) Fumarate salt of (alpha s, beta r)-6- bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
WO2007135193A3 (fr) Forme pharmaceutique orale multimicroparticulaire a liberation prolongee comprenant des moyens anti-mesusage et resistant a l'alcool
TW200738228A (en) Neramexane modified release matrix tablet
MX2010003439A (es) Combinacion farmaceutica de aliskiren y valsartan.
MX341015B (es) Forma de dosificacion de liberacion extendida.
WO2012020301A3 (en) Oral controlled release pharmaceutical compositions of blonanserin
PT1651248E (pt) Composições farmacêuticas para dose oral compreendendo um agente de administração na forma micronizada
SG152257A1 (en) Topical preparation containing ambroxol
IL174830A0 (en) Pellets containing venlafaxine hydrochloride, pharmaceutical compositions comprising them and processes for their preparation
IL164903A0 (en) Processes for preparation of polymorphic form II of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
BRPI0513598A (pt) formas de dosagem em comprimidos revestidos de liberação entérica
WO2009095395A3 (en) Pharmaceutical compositions
TNSN06242A1 (en) Extended release coated minitablets of venlafaxine hydrochloride
WO2007119249A3 (en) Pharmaceutical compositions of cefixime
MX2009006735A (es) Capsulas de gelatina que comprenden un acido.
TW200716114A (en) Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
WO2006054175A3 (en) Stable dosage forms of acid labile drug
UA88186C2 (ru) Расагилиновые формуляции с улучшенной однородностью содержимого
WO2007052152A3 (en) Sertraline oral concentrate